FDA Inspection 1123434 — Bayer AG

Bayer AG — FEI 3003229486

The FDA completed an inspection of Bayer AG on Jul 11, 2019 in Wuppertal. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 11, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wuppertal (Germany)

Additional Details

Mutual Recognition Agreement (MRA)